{"id":"W2139596299","doi":"10.1016/j.radonc.2008.04.005","title":"A novel poly(ADP-ribose) polymerase inhibitor, ABT-888, radiosensitizes malignant human cell lines under hypoxia","year":2008,"lang":"en","type":"article","venue":"Radiotherapy and Oncology","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":137,"is_retracted":false,"has_abstract":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; University of Toronto","funders":"Abbott Laboratories","keywords":"Poly ADP ribose polymerase; Cancer research; Clonogenic assay; PARP inhibitor; Radiosensitivity; Radioresistance; DNA repair; DNA damage; Cell culture; Chemistry; Radiation therapy; Tumor hypoxia; Prostate cancer; Cancer cell; Cancer; Cell; Biology; Polymerase; Medicine; Enzyme; DNA; Biochemistry; Internal medicine; Genetics","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002408606,0.0004261781,0.0008986177,0.0002898921,0.0004341896,0.0000208941,0.0001194354,0.0004407505,0.0004869618],"category_scores_gemma":[0.00001160787,0.0003796535,0.0002069749,0.0002717239,0.0006914589,0.0001205438,0.00002579718,0.0004025819,0.00001982509],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006093892,"about_ca_system_score_gemma":0.0004350977,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001869515,"about_ca_topic_score_gemma":0.00004649062,"domain_scores_codex":[0.9977158,0.0001442166,0.0005955067,0.000634677,0.0003014975,0.0006083414],"domain_scores_gemma":[0.9986091,0.000225486,0.0002299525,0.0004451608,0.0001087336,0.0003816172],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.001137824,0.001072414,0.001440303,0.00005670355,0.0001939263,0.0004349805,0.001381769,0.000008829975,0.9792792,0.0007671785,0.009993861,0.004233],"study_design_scores_gemma":[0.04965609,0.008288098,0.02948727,0.0002662266,0.0002416835,0.0159501,0.000546128,0.0002817986,0.5715943,0.0004184519,0.3218419,0.001427959],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9610924,0.02239987,0.002056832,0.01018583,0.0008578798,0.0006189648,0.00004512688,0.0002177063,0.002525404],"genre_scores_gemma":[0.9599965,0.00717269,0.006717816,0.01637465,0.00402644,0.00007683122,0.00005365839,0.0001277825,0.005453631],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.407685,"threshold_uncertainty_score":0.9998655,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03592418584567387,"score_gpt":0.3163976511884213,"score_spread":0.2804734653427475,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}